Back to DE D. E. Shaw & Co., Inc.

TVTXTVTX
Showing 8 of 23 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in TRAVERE THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 1.4M shares of TVTX (TRAVERE THERAPEUTICS INC), worth $81.8M as of 2026-Q2. The position was increased (+72.2% shares). TVTX represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$81.8M

Current Shares

1.4M

Total Value Change

+$56.1M

Total Shares Change

-399,600

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+72.2%
$81.8M0.0%$56.81
45
2026-Q1
Decreased
836,544
-23.6%
$24.9M0.0%$28.27
0
2025-Q4
Increased
1.1M
+65.0%
$41.8M0.0%$37.68
43
2025-Q3
Decreased
663,252
-41.3%
$15.9M0.0%$24.04
0
2025-Q2
Decreased
1.1M
-34.0%
$16.7M0.0%$14.77
0
2025-Q1
Decreased
1.7M
-24.8%
$30.7M0.0%$19.68
0
2024-Q4
Increased
2.3M
+23.8%
$39.7M0.0%$17.32
35
2024-Q3
Increased
1.8M
+20.0%
$25.7M0.0%$14.01
34

Other major holders of TVTX: BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used